We present the results of a prospective multicenter study risk factors, etiology, clinical features, and treatment outcomes for mucormycosis in patients with COVID-19 (COVID-M) Russian Federation. The included 60 adult COVID-M. To analyze factors COVID-M, we conducted case-control study. control group without mucormycosis. manifestations created hematological examined 2011–2020. In COVID-19, de...

Fungal infections are on rise globally owing to use of immunosuppressant drugs for various diseases, increased antimicrobials and in-situ devices, long duration stay in hospitalized patients. There was sharp mucormycosis patients post COVID 19 illness which were previously limited end stage diabetic ketoacidosis. We studied the epidemiological, clinical, microbiological radiological aspects cul...

Rapid detection and differentiation of Aspergillus and Mucorales species in fungal rhinosinusitis diagnosis are desirable, since the clinical management and prognosis associated with the two taxa are fundamentally different. We describe an assay based on a combination of broad-range PCR amplification and reverse line blot hybridization (PCR/RLB) to detect and differentiate the pathogens causing...